White House prepares to replace FDA leader Marty Makary amid agency turmoil - The Washington Post

• • President Trump moved to replace FDA Commissioner Marty Makary following conflicts over vaping, drug approvals, and the abortion pill.


• • Makary resigned in May 2026, leading to a period of acting leadership under Kyle Diamantas.


• • Heidi Overton was selected by August 2026 to lead the agency as an America First ally.

Context
The FDA faced significant internal turmoil, staff losses, and intense pressure from industry lobbyists and anti-abortion activists. Leadership clashes centered on the agency's role in regulating controversial medical and social issues.

Christian Perspective
The friction regarding the abortion pill is a necessary battle to protect the sanctity of life against a secular bureaucracy. Replacing career bureaucrats with America First allies ensures that the agency respects the biological reality of life and the moral order.

Implications
This shift signals a move away from globalist health agendas toward policies that protect the American family. It empowers the administration to curb the influence of entities that promote abortion and chemical dependency.

Broader Trends
This reflects a wider purge of the administrative state to dismantle the deep state's influence over national health. It is part of a larger effort to reclaim sovereignty from unelected officials who subvert traditional values.

Takeaway
Support leaders who prioritize the protection of life and the health of the American people over corporate interests. Demand an America First approach in all regulatory agencies to ensure they serve the nation rather than globalist agendas.